retatrutide first week UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide Dosing Guide: 1-12 mg

In March 2025, Roche and Zealand Pharma launched an Up-to-$5.3B obesity collaboration to co-develop and co-commercialize Zealands petrelintide for overweight and obesity indications

It may also improve metabolic health factors linked to sleep apnea severity

Answer: Retatrutide trials focus on adults with obesity or overweight, typically a BMI at or above 27, who also carry a weight-related condition such as type 2 diabetes, pre-diabetes, high blood pressure, or high cholesterol

Heine RJ, Van Gaal LF, Johns D et al

Keep ambient-temperature handling time as short as practical to support compound integrity

But here is the critical distinction